Infectious Bursal Disease Vaccine Market size was valued at USD 400 Million in 2024 and is projected to reach USD 600 Million by 2033, exhibiting a CAGR of 5% from 2026 to 2033.
The Infectious Bursal Disease Vaccine Market in South Korea has been witnessing significant growth, driven by the increasing demand from the poultry industry. This market primarily caters to the need for vaccines that protect poultry from Infectious Bursal Disease (IBD), a viral infection that affects chickens, leading to substantial economic losses. IBD can severely impact the immune system of poultry, making them susceptible to other infections and affecting the quality and quantity of egg production. The growing awareness of these risks and the advancement in vaccine technology are expected to drive the vaccine market further in South Korea.
The demand for Infectious Bursal Disease vaccines is largely shaped by the poultry industry's rapid expansion in the country. South Korea, being one of the leading poultry producers in Asia, has been actively working to improve biosecurity measures. Poultry farms are increasingly adopting preventive health measures, including vaccination, to ensure the overall health of their flocks. The government, alongside veterinary organizations, plays a significant role in promoting the importance of vaccination and the adoption of best practices to combat infectious diseases like IBD.
In terms of market types, the South Korean Infectious Bursal Disease Vaccine Market includes live attenuated vaccines, inactivated vaccines, and recombinant vaccines. Live vaccines are typically used in large commercial farms due to their cost-effectiveness, while inactivated vaccines are preferred for their safety, especially in areas with a high risk of infection. Recombinant vaccines are gaining popularity as they provide enhanced protection and fewer side effects compared to traditional vaccines.
In addition to the poultry industry, industries such as animal health, veterinary services, and pharmaceuticals are significant contributors to the market’s growth. Poultry farmers are increasingly turning to advanced vaccine formulations to prevent the spread of IBD within their flocks. The surge in demand for high-quality poultry products, including eggs and meat, is also driving the need for these vaccines, as healthy flocks are essential to meeting both domestic and international market needs.
The South Korean Infectious Bursal Disease Vaccine Market is expected to continue its growth trajectory, propelled by these industry requirements and advancements in vaccine technology. With increased awareness and the continuous improvement of vaccine formulations, the market is set to evolve further in the coming years, catering to both local and international poultry health standards.
Get an In-Depth Research Analysis of the South Korea Infectious Bursal Disease Vaccine Market Size And Forecast [2025-2032]
Zoetis
Merck
Elanco
Boehringer Ingelheim
Ceva
Qingdao Yibang Biological Engineering Co.
Ltd.
Shandong Lvdu Biological Technology Co.
Ltd.
Plyco Bioengineering Co.
Ltd.
Ruipu Biopharmaceutical Co.
Ltd.
Harbin Pharmaceutical Group Biological Vaccine Co.
Ltd.
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Infectious Bursal Disease Vaccine Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Infectious Bursal Disease Vaccine Market
Live Attenuated Vaccines
Inactivated Vaccines
Recombinant Vaccines
DNA Vaccines
Oral Vaccines
Injectable Vaccines
Nasal Vaccines
Day-Old Chicks
Young Birds
Adult Birds
Suspensions
Lyophilized (Freeze-dried) Formulations
Emulsions
Veterinary Clinics
Online Pharmacies
Pharmaceutical Distribution Companies
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Infectious Bursal Disease Vaccine Market Research Analysis
1. Introduction of the South Korea Infectious Bursal Disease Vaccine Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Infectious Bursal Disease Vaccine Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Infectious Bursal Disease Vaccine Market, By Type
6. South Korea Infectious Bursal Disease Vaccine Market, By Application
7. South Korea Infectious Bursal Disease Vaccine Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Infectious Bursal Disease Vaccine Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/